Lilian Sattler First UGA Georgia CTSA KL2 Scholar
Lilian Sattler, PhD, assistant professor with a dual appointment in the UGA College of Pharmacy and the College of Family and Consumer Sciences, is the first Georgia Clinical & Translational Science Alliance (Georgia CTSA) KL2 scholar named from the University of Georgia.
The goal of the Georgia CTSA KL2-Mentored Clinical and Translational Research Scholars program is to support and enhance career development for junior faculty (MD, PhD, MD/PhD, or PharmD) from a wide variety of disciplines at Emory University, Morehouse School of Medicine, Georgia Institute of Technology, and the University of Georgia College of Pharmacy. The Georgia CTSA KL2 program is committed to assisting junior faculty at partner institutions to become independent, established, and ethical clinical and/or translational research investigators.
Sattler’s clinical KL2 research project is entitled “Effect of Dietary Approaches to Stop Hypertension Eating Pattern of Hemodynamic Markers in Advanced Heart Failure Patients.” With guidance from her experienced, interinstitutional and interdisciplinary KL2 mentorship team, including Sandra Dunbar PhD, RN, FAAN, FAHA, FPCNA, Emory University Nell Hodgson Woodruff School of Nursing (primary mentor 1); Arshed A. Quyyumi, MD, FACC, FRCP, Emory University School of Medicine (primary mentor 2); Jonathan R. Murrow, MD, FACC, Augusta University/UGA Medical Partnership; Henry N. Young, PhD, UGA College of Pharmacy; and Rick D. Lewis, PhD, RD, FACSM, UGA College of Family and Consumer Sciences, the feeding trial will examine the effect of nutritional intake on hemodynamic markers, cardiometabolic markers, and medication regimen changes in advanced heart failure patients with implanted hemodynamic monitoring device.
As a KL2 scholar, Sattler will receive salary support to allow her to spend 75 percent of her professional time on research over two years. She will also receive a $25,000 per year technical budget for research-related expenses and complete 16 credits of formal training through the Emory University Certificate Program in Translational Research (CPTR). “I am excited about the training opportunities and new infrastructure the Georgia CTSA holds for early-career investigators like me who are trying to launch a career in clinical research, and I feel honored that a team of such accomplished researchers has agreed to mentor me throughout this process,” said Sattler.
“The KL2 program is a unique and highly successful training opportunity for junior faculty. Please join me in congratulating Dr. Sattler on this significant achievement and being UGA’s first KL2 Scholar,” said Bradley G. Phillips, PharmD, director of the Clinical and Translational Research Unit and Georgia CTSA principal investigator for UGA.